tiprankstipranks
C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market

C4 Therapeutics (CCCC) Cash flow

376 Followers

C4 Therapeutics Cash Flow

CCCC's free cash flow for Q4 2023 was $―. For the 2023 fiscal year, CCCC's free cash flow was decreased by $-105.27M and operating cash flow was $-24.01M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -87.45M$ -106.84M$ -3.28M$ -86.97M$ -67.25M$ 55.61M
Investing Cash Flow
$ 143.20M$ 158.35M$ 58.42M$ -189.34M$ -190.50M$ -1.62M
Financing Cash Flow
$ 46.23M$ 45.49M$ 1.15M$ 171.40M$ 348.93M$ 244.00K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 295.31M$ 130.03M$ -3.28M$ 79.40M$ 184.30M$ 93.13M
Income Tax Paid Supplemental Data
$ 1.00M$ 1.00M--$ 143.00K$ 1.09M
Interest Paid Supplemental Data
$ 568.00K$ 990.00K$ 1.62M$ 1.31M$ 820.00K$ 0.00
Issuance Of Capital Stock
$ 57.67M$ 57.67M--$ 340.60M$ 0.00
Issuance Of Debt
$ -11.75M$ -12.50M--$ 11.97M$ 0.00
Repayment Of Debt
$ -750.00K$ -12.50M----
Free Cash Flow
$ -33.32M$ -108.55M$ -3.28M$ -88.24M$ -67.90M$ 54.27M
Domestic Sales
------
Foreign Sales
------
Currency in USD

C4 Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis